Hebert L E, Scherr P A, Beckett L A, Albert M S, Pilgrim D M, Chown M J, Funkenstein H H, Evans D A
Rush Institute on Aging, Chicago, IL 60612, USA.
JAMA. 1995 May 3;273(17):1354-9.
To determine age-specific incidence rates of clinically diagnosed Alzheimer's disease.
Cohort, followed a mean of 4.3 years.
East Boston, Mass.
Of 2313 persons aged 65 years and older who were initially free of Alzheimer's disease, 1601 participated in the ascertainment of incident disease (80% of survivors), 409 declined participation, and 303 died before the end of the follow-up period. A stratified sample of 642 persons received detailed clinical evaluation.
Diagnosis of new probable Alzheimer's disease through structured clinical evaluation including neurologic, neuropsychological, and psychiatric examination. Community incidence rates were computed by 5-year age groups, adjusted for gender, single year of age, length of follow-up interval, and sampling design.
The estimated annual incidence of Alzheimer's disease in the population was 0.6% (95% confidence interval [CI], 0.3% to 0.9%) for persons aged 65 to 69 years, 1.0% (95% CI, 0.6% to 1.4%) for persons aged 70 to 74 years, 2.0% (95% CI, 1.3% to 2.7%) for persons aged 75 to 79 years, 3.3% (95% CI, 2.2% to 4.4%) for persons aged 80 to 84 years, and 8.4% (95% CI, 3.7% to 13.1%) for persons aged 85 years and older.
The incidence of Alzheimer's disease is substantial and is approximately 14 times higher among persons older than 85 years compared with those between 65 and 69 years of age.
确定临床诊断的阿尔茨海默病的年龄特异性发病率。
队列研究,平均随访4.3年。
马萨诸塞州东波士顿。
在2313名65岁及以上且最初无阿尔茨海默病的人群中,1601人参与了新发疾病的确定(占幸存者的80%),409人拒绝参与,303人在随访期结束前死亡。对642人的分层样本进行了详细的临床评估。
通过包括神经学、神经心理学和精神科检查在内的结构化临床评估诊断新的可能的阿尔茨海默病。按5岁年龄组计算社区发病率,并对性别、单一年龄、随访间隔长度和抽样设计进行调整。
65至69岁人群中阿尔茨海默病的估计年发病率为0.6%(95%置信区间[CI],0.3%至0.9%),70至74岁人群为1.0%(95%CI,0.6%至1.4%),75至79岁人群为2.0%(95%CI,1.3%至2.7%),80至84岁人群为3.3%(95%CI,2.2%至4.4%),85岁及以上人群为8.4%(95%CI,3.7%至13.1%)。
阿尔茨海默病的发病率很高,85岁及以上人群的发病率比65至69岁人群高约14倍。